Competitive disruption from organized chains entering radiology
Large pathology chains are venturing into advanced radiology, potentially increasing competition in core and new markets.
VIJAYADIAGNOSTICCENTRE / Q3-FY26 / risks
Keep the risk register visible.
Vijaya Diagnostic Centre · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Realization dilution from pathology mix shift
As new hubs stabilize, higher pathology share could reduce revenue per test, though tariff hikes may offset.
Currency and GST impact on capex
USD/INR volatility and GST changes could affect equipment costs, though management expects minimal net impact.
Execution risk in new geography expansion
Rapid hub and spoke expansion in West Bengal, Bangalore, and Pune may strain operational bandwidth and delay stabilization.